NITRILE-CONTAINING ANTIVIRAL COMPOUNDS

The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SAMMONS, Matthew Forrest, REESE, Matthew Richard, WEI, Liuqing, TUTTLE, Jamison Bryce, YANG, Qingyi, VERHOEST, Patrick Robert, PETTERSSON, Martin Youngjin, OWEN, Dafydd Rhys, YANG, Xiaojing
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SAMMONS, Matthew Forrest
REESE, Matthew Richard
WEI, Liuqing
TUTTLE, Jamison Bryce
YANG, Qingyi
VERHOEST, Patrick Robert
PETTERSSON, Martin Youngjin
OWEN, Dafydd Rhys
YANG, Xiaojing
description The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA202108834B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA202108834B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA202108834B3</originalsourceid><addsrcrecordid>eNrjZFDz8wwJ8vRx1XX29wtx9PTz9HNXcPQL8QzzDHL0UXD29w3wD_VzCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGRoYGFhbGJk7GxKgBAOahI-s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><source>esp@cenet</source><creator>SAMMONS, Matthew Forrest ; REESE, Matthew Richard ; WEI, Liuqing ; TUTTLE, Jamison Bryce ; YANG, Qingyi ; VERHOEST, Patrick Robert ; PETTERSSON, Martin Youngjin ; OWEN, Dafydd Rhys ; YANG, Xiaojing</creator><creatorcontrib>SAMMONS, Matthew Forrest ; REESE, Matthew Richard ; WEI, Liuqing ; TUTTLE, Jamison Bryce ; YANG, Qingyi ; VERHOEST, Patrick Robert ; PETTERSSON, Martin Youngjin ; OWEN, Dafydd Rhys ; YANG, Xiaojing</creatorcontrib><description>The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19.</description><language>eng</language><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230426&amp;DB=EPODOC&amp;CC=ZA&amp;NR=202108834B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230426&amp;DB=EPODOC&amp;CC=ZA&amp;NR=202108834B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAMMONS, Matthew Forrest</creatorcontrib><creatorcontrib>REESE, Matthew Richard</creatorcontrib><creatorcontrib>WEI, Liuqing</creatorcontrib><creatorcontrib>TUTTLE, Jamison Bryce</creatorcontrib><creatorcontrib>YANG, Qingyi</creatorcontrib><creatorcontrib>VERHOEST, Patrick Robert</creatorcontrib><creatorcontrib>PETTERSSON, Martin Youngjin</creatorcontrib><creatorcontrib>OWEN, Dafydd Rhys</creatorcontrib><creatorcontrib>YANG, Xiaojing</creatorcontrib><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><description>The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDz8wwJ8vRx1XX29wtx9PTz9HNXcPQL8QzzDHL0UXD29w3wD_VzCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGRoYGFhbGJk7GxKgBAOahI-s</recordid><startdate>20230426</startdate><enddate>20230426</enddate><creator>SAMMONS, Matthew Forrest</creator><creator>REESE, Matthew Richard</creator><creator>WEI, Liuqing</creator><creator>TUTTLE, Jamison Bryce</creator><creator>YANG, Qingyi</creator><creator>VERHOEST, Patrick Robert</creator><creator>PETTERSSON, Martin Youngjin</creator><creator>OWEN, Dafydd Rhys</creator><creator>YANG, Xiaojing</creator><scope>EVB</scope></search><sort><creationdate>20230426</creationdate><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><author>SAMMONS, Matthew Forrest ; REESE, Matthew Richard ; WEI, Liuqing ; TUTTLE, Jamison Bryce ; YANG, Qingyi ; VERHOEST, Patrick Robert ; PETTERSSON, Martin Youngjin ; OWEN, Dafydd Rhys ; YANG, Xiaojing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA202108834B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>SAMMONS, Matthew Forrest</creatorcontrib><creatorcontrib>REESE, Matthew Richard</creatorcontrib><creatorcontrib>WEI, Liuqing</creatorcontrib><creatorcontrib>TUTTLE, Jamison Bryce</creatorcontrib><creatorcontrib>YANG, Qingyi</creatorcontrib><creatorcontrib>VERHOEST, Patrick Robert</creatorcontrib><creatorcontrib>PETTERSSON, Martin Youngjin</creatorcontrib><creatorcontrib>OWEN, Dafydd Rhys</creatorcontrib><creatorcontrib>YANG, Xiaojing</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAMMONS, Matthew Forrest</au><au>REESE, Matthew Richard</au><au>WEI, Liuqing</au><au>TUTTLE, Jamison Bryce</au><au>YANG, Qingyi</au><au>VERHOEST, Patrick Robert</au><au>PETTERSSON, Martin Youngjin</au><au>OWEN, Dafydd Rhys</au><au>YANG, Xiaojing</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><date>2023-04-26</date><risdate>2023</risdate><abstract>The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA202108834B
source esp@cenet
title NITRILE-CONTAINING ANTIVIRAL COMPOUNDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A25%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAMMONS,%20Matthew%20Forrest&rft.date=2023-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA202108834B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true